June 15, 2023
Pfizer warns FDA of penicillin shortage
Editor's Note
Pfizer alerted the Food and Drug Administration (FDA) on June 12 that its supply of two forms of injectable penicillin—Bicillin L-A and Bicillin C-R—may run out by the end of this month, the June 13 The Hill reports.
Pfizer cited a combination of factors for the shortage, including an increase in demand and a rise in syphilis cases.
The company estimates that supplies of Bicillin C-R would run out by the third quarter of this year, and the pediatric pre-filled syringes of Bicillin L-A would run out even earlier.
Free Daily News
- Healthcare employment up in November
- Nonprofit hospitals face ongoing struggles in 2024
- ASCs lock in higher Medicare, Medicaid payment rate
- HHS releases concept paper on cybersecurity for healthcare sector
- Study examines infection precautions during pandemic based on healthcare roles
- Postoperative opioid prescriptions falling, but more improvement needed
- New protein calculation uncovers which organs are aging at an accelerated pace
- Researchers are calling for better tracking of chronic diseases
- New Joint Commission certification addresses secondary use of data
- New wearable device system could aid in remote medical monitoring
© Access Intelligence, LLC. All rights reserved. | Privacy Policy | Diversity, Equity, Inclusion & Belonging